Please join us on Thursday, April 28th at 5:00 pm EST (4:00 pm CST/2:00 pm PST) for a webinar about the HEALEY ALS Platform Trial and a special introduction to Kelly G. Gwathmey M.D., site investigator at Virginia Commonwealth University. Sabrina Paganoni, MD, Ph.D., and Merit Cudkowicz, MD, MSc will present this week’s updates on the HEALEY ALS Platform Trial and answer questions from the audience.
|
|
Kelly G. Gwathmey M.D. is a neurologist at Virginia Commonwealth University, serves as a site investigator for the Platform Trial, and is an assistant professor of neurology at the VCU School of Medicine. Her research interests include studying the quality of life instruments in neuromuscular diseases
|
|
